NIH-AACR Cancer, Autoimmunity, and Immunology Conference

April 15-16, 2019
National Institutes of Health Masur Auditorium
Bethesda, Maryland

Organizing Committee
Elizabeth M. Jaffee, MD, 2018-2019 AACR President, Deputy Director, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Elad Sharon, MD, MPH, Senior Investigator, National Cancer Institute
Connie Sommers, PhD, Program Director, National Cancer Institute
Howard Young, PhD, Senior Investigator, National Cancer Institute
Katarzyna (Kasia) Bourcier, PhD, Program Officer, National Institute of Allergy and Infectious Diseases
Marie Mancini, PhD, Program Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Held for the first time in 2018, the Cancer, Autoimmunity, and Immunology Conference was created to delve into 1) understanding the biology of immune-related adverse events that have occurred in cancer patients treated with immunotherapies and how that might inform the study of autoimmune disease; and 2) defining the potential for the study of autoimmune disease to lead to greater understanding of the treatment and management of immune-related adverse events during and following cancer therapies.

This year, the NIH-AACR Cancer, Autoimmunity, and Immunology Conference will feature sessions focusing on gastrointestinal, neurological, ocular, and skin toxicities; and the use of pre-clinical models and meta-analyses for interrogating immune-related adverse events. There will be Keynote Presentations from Arlene H. Sharpe, MD, PhD; Elizabeth M. Jaffee, MD; and Jennifer A. Wargo, MD, MMSc.

CME-MOC_badge_170x.jpgContinuing Medical Education Activity AMA PRA Category 1 CreditsTM available